A "Trojan horse" drug gets into the tumor and kills it from the inside

A "Trojan Horse" drug that attacks tumor cells from within can offer new hope to cancer patients with few options, doctors said.

The new treatment has generated promising results in people with six different types of cancer, including cervical, bladder, ovarian and lung cancers, according to the results of the first trials published in the journal & # 39; The Lancet Oncology & # 39 ;.

The drug – tisotumab vedotin (TV) – has been tested in patients with advanced cancer who no longer responded to standard therapy and caused the narrowing of certain tumors.

"Its mechanism of action is completely new – it acts as a Trojan horse to infiltrate cancer cells and kill them from within," said principal professor Johann de Bono.

Independent Irish